GH Research

(NASDAQ) GHRS

Current Price$21.08

Market Cap$1.45B

Since IPO (2021)+10%

5 YearN/A

1 Year+65%

1 Month-3%

GH Research Financials at a Glance

Market Cap

$1.45B

Revenue (TTM)

$0.00

Net Income (TTM)

-$56.41M

EPS (TTM)

-$0.91

P/E Ratio

-23.22

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$21.08

Volume

181,084.577

Open

$20.85

Price

$21.08

Volume

181,084.577

Open

$20.85

Previous Close

$21.12

Daily Range

$20.68 - $22.06

52-Week Range

$11.32 - $25.94

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$21.08

Volume

181,084.577

Open

$20.85

Previous Close

$21.12

Daily Range

$20.68 - $22.06

52-Week Range

$11.32 - $25.94

Estimated Earnings Date

Aug 6, 2026

GHRS News

Best Psychedelic Stocks to Buy in 2026 and How to Invest

Keith SpeightsApr 10, 2026

GHRS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GH Research

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Villy Valcheva, MD

Website

www.ghres.com

Headquarters

Dublin, D02 NX43, IE

GHRS Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-20%

Return on Capital

-25%

Return on Assets

-20%

Earnings Yield

-4.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.45B

Shares Outstanding

68.56M

Volume

181.08K

Avg. Volume

229.19K

Financials (TTM)

Gross Profit

-$335.00K

Operating Income

-$60.68M

EBITDA

-$47.46M

Operating Cash Flow

-$43.55M

Capital Expenditure

-$121.00K

Free Cash Flow

-$43.67M

Cash & ST Invst.

$280.71M

Total Debt

$512.00K

GH Research Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$91.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.45B

N/A

Market Cap/Employee

$28.96M

N/A

Employees

N/A

Net Income

-$18.97M

-75.4%

EBITDA

-$18.79M

-75.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$267.33M

-8.2%

Total Debt

$432.00K

-34.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$75.00K

-76.7%

Short Term Debt

$357.00K

+6.3%

Return on Assets

-20.49%

N/A

Return on Invested Capital

-25.31%

N/A

Free Cash Flow

-$10.73M

-25.1%

Operating Cash Flow

-$10.67M

-24.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TYRATyra Biosciences, Inc.

TYRATyra Biosciences, Inc.$26.99+5.55%

PVLAPalvella Therapeutics, Inc.

PVLAPalvella Therapeutics, Inc.$108.81+2.28%

NBTXNanobiotix S.A.

NBTXNanobiotix S.A.$35.54+0.59%

SVRASavara Inc.

SVRASavara Inc.$5.26-0.19%

SPRYARS Pharmaceuticals, Inc.

SPRYARS Pharmaceuticals, Inc.$9.76+1.77%

ABUSArbutus Biopharma Corporation

ABUSArbutus Biopharma Corporation$4.26-0.70%

KURAKura Oncology, Inc.

KURAKura Oncology, Inc.$9.05+2.14%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About GHRS

What is the current price of GH Research?

GH Research is trading at $21.12 per share.

What is the 52-week range for GH Research?

Over the past 52 weeks, GH Research has traded between $11.32 and $25.94.

How much debt does GH Research have?

As of the most recent reporting period, GH Research reported total debt of $432.00K.

How much cash does GH Research have on hand?

GH Research reported $242.65M in cash and cash equivalents in its most recent financial results.

What is GH Research’s dividend yield?

GH Research does not currently have a dividend yield.

GH Research

GH Research Financials at a Glance

GHRS News

Best Psychedelic Stocks to Buy in 2026 and How to Invest

GHRS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About GH Research

GHRS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

GH Research Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GHRS

What is the current price of GH Research?

What is the 52-week range for GH Research?

How much debt does GH Research have?

How much cash does GH Research have on hand?

What is GH Research’s dividend yield?

Premium Investing Services